Paul Schroy | Profiles RNS

Paul C. Schroy III, MD, MPH

Emeritus Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Gastroenterology

MD, Thomas Jefferson University
MPH, Boston University School of Public Health
BS, Haverford College

Websites

	Boston Medical Center Provider Profile
	ResearchGate

ORCID : 0000-0001-9273-7832

Dr. Paul C. Schroy is Emeritus Professor of Medicine at Chobanian and Avedisian School of Medicine with expertise in the area of colorectal cancer screening and surveillance. He has over 150 publications, and received research funding from NCI, AHRQ, CDC and ACS. Dr. Schroy’s most recent research activities have focused primarily on the development, implementation and evaluation of model programs for community-based colorectal cancer control, including: (1) exploring the role of shared decision-making as a strategy for increasing patient participation in colorectal cancer screening; (2) better defining the epidemiology of colorectal neoplasia and the development of risk assessment tools for predicting the presence of advanced neoplasia at screening colonoscopy; (3) evaluating the feasibility and validity of novel colorectal cancer screening strategies such as stool-based DNA testing and virtual colonoscopy; (4) implementation of quality measures related to colorectal cancer screening; and (5) developing strategies to reduce the public health burden of early-onset colorectal cancer.

In addition to his commitment to patient care and clinical research, Dr. Schroy is a founding member and former chair of the Massachusetts Colorectal Cancer Working Group and a founding member of the National Colorectal Cancer Roundtable. He has served in numerous leadership positions for the Roundtable, including current co-chair of the Family History and Early Onset Colorectal Cancer Task Group, former member of the Steering Committee, former co-chair of the Public Education Task Group, former co-chair of the Screening 65+ Task Group, and former chair of the Nomination Committee. He is also a former member of the Steering Committee of the Massachusetts Comprehensive Cancer Prevention and Control Network, the American Cancer Society’s New England Division’s Colorectal Cancer Advisory Committee and the Massachusetts Department of Public Health’s Cancer Registry Advisory Committee.

Member
Boston University
BU-BMC Cancer Center

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

Multi Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer: DeeP-C Study Protocol #2011-01
02/01/2012 - 01/31/2014 (PI)
Exact Sciences

Multi Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer: DeeP-C Study
02/01/2012 - 01/31/2014 (PI)
Exact Sciences

Effect of Sample Storage Conditions on the Detection of Colorectal Neoplasia by Stool Based DNA Technology Advances
01/01/2004 - 12/31/2004 (PI)
Exact Sciences

Molecular Diagnostic Assay for Colorectal Cancer
06/01/2003 - 05/31/2004 (PI)
AmberGen, Inc.

A Preference for CRC Screening in Average Risk Patients
09/01/2002 - 12/31/2003 (PI)
Exact Sciences

Sensitivity of the Exact Panel In Determination of Colorectal Cancer
10/01/2001 - 09/30/2002 (PI)
Exact Sciences

New Strategies for Colorectal Cancer Control
09/30/1996 - 09/29/2001 (PI)
NIH/National Cancer Institute
5 K07 CA68058 05

GI Quality Improvement Contract
10/06/2008 - 06/30/2017 (PI)
DPH

Intervention Study of Patient Navigation for Colonoscopy Screening
08/01/2012 - 01/15/2016 (PI)
WESTAT CDC

A Risk Prediction Model for Colorectal Cancer Screening
09/15/2008 - 07/31/2014 (PI)
NIH-NCI
5R01 CA131197-05

I CAN! (Improving Colonoscopy Access through Navigation)
05/01/2011 - 07/31/2012 (PI)
Harvard Pilgrim Health Care (HPHC)

Patient Navigation for Colorectal Cancer Screening
08/19/2011 - 09/21/2011 (PI)
WESTAT CDC

Shared Decision Making for Colorectal Cancer Screen
09/30/2003 - 09/30/2009 (PI)
DHHS/AHRQ
5 R01 HS013912-05

BMC Endoscopy Quality Improvement Training and Education
04/15/2008 - 06/30/2008 (PI)
Adcare Educational Institute DPH

Promoting Colon Cancer Screeni
09/30/2001 - 08/31/2005 (PI)
NIH-NCI
1K22CA9068003 (A)

Title

Yr	Title	Project-Sub Proj	Pubs
2012	A Risk Prediction Model for Colorectal Cancer Screening	5R01CA131197-05	5
2011	A Risk Prediction Model for Colorectal Cancer Screening	5R01CA131197-04	5
2010	A Risk Prediction Model for Colorectal Cancer Screening	5R01CA131197-03	5
2009	A Risk Prediction Model for Colorectal Cancer Screening	5R01CA131197-02	5
2008	A Risk Prediction Model for Colorectal Cancer Screening	1R01CA131197-01A1	5
2007	Shared Decision-Making for Colorectal Cancer Screening	5R01HS013912-05	5
2006	Shared Decision-Making for Colorectal Cancer Screening	5R01HS013912-04	5
2005	Shared Decision-Making for Colorectal Cancer Screening	5R01HS013912-03	5
2004	Shared Decision-Making for Colorectal Cancer Screening	5R01HS013912-02	5
2003	Shared Decision-Making for Colorectal Cancer Screening	1R01HS013912-01	5

Showing 10 of 18 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Connolly JJ, Ahmed HS, Chung EC, Cabral HJ, Nagar A, Tami A, Schroy PC, Mohanty A. Estimate of Increase in Colorectal Cancer Diagnoses with Expansion of Fecal Immunochemical Testing in an Urban Safety-Net Population. Dig Dis Sci. 2024 Feb; 69(2):360-369.View Related Profiles.

Mohanty, Arpan
Ahmed, Heidi
Cabral, Howard
Schroy, Paul

PMID: 38041763

Ahmed HS, Connolly JJ, Chung EC, Cabral HJ, Schroy PC, Mohanty A. Adaptive Strategies for Outpatient Colonoscopies in Response to COVID-19. Am J Prev Med. 2023 Jan; 64(1):122-124.View Related Profiles.

Mohanty, Arpan
Ahmed, Heidi
Cabral, Howard
Schroy, Paul

PMID: 36116997; PMCID: PMC9420719; DOI: 10.1016/j.amepre.2022.08.002;

Rebello D, Schroy PC, Leszcynski A, Colletta A, Rebello E, Mills J, Heeren T, Roy H. Prevalence of Metachronous Advanced Colorectal Neoplasia in Black and White Patients at a Safety Net Hospital. Gastro Hep Adv. 2022; 1(1):14-22.View Related Profiles.

Roy, Hemant
Schroy, Paul
Heeren, Timothy

PMID: 39129928; PMCID: PMC11307537; DOI: 10.1016/j.gastha.2021.09.001;

Trivedi PD, Mohapatra A, Morris MK, Thorne SA, Smith SC, Ward AM, Schroy P, Hampel H, Jandorf L, Popp JW, Itzkowitz SH. Prevalence and Predictors of Young-Onset Colorectal Neoplasia: Insights From a Nationally Representative Colonoscopy Registry. Gastroenterology. 2022 04; 162(4):1136-1146.e5. PMID: 35007513

Jones WF, Ahnen DJ, Schroy PC. Improving on-time colorectal cancer screening through lead time messaging. Cancer. 2020 01 15; 126(2):247-252. PMID: 31568559

DeGroff A, Schroy PC, Morrissey KG, Slotman B, Rohan EA, Bethel J, Murillo J, Ren W, Niwa S, Leadbetter S, Joseph D. Patient Navigation for Colonoscopy Completion: Results of an RCT. Am J Prev Med. 2017 Sep; 53(3):363-372. PMID: 28676254; PMCID: PMC8855664; DOI: 10.1016/j.amepre.2017.05.010;

Kluge MA, Williams JL, Wu CK, Jacobson BC, Schroy PC, Lieberman DA, Calderwood AH. Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy. Gastrointest Endosc. 2018 Mar; 87(3):744-751.View Related Profiles.

Jacobson, Brian
Schroy, Paul

PMID: 28648575; PMCID: PMC5742069; DOI: 10.1016/j.gie.2017.06.012;

Le ST, Lash BR, Schroy PC, Calderwood AH. Physician Perceptions of Surveillance Follow-up Colonoscopy in Older Adults. J Am Board Fam Med. 2017 May-Jun; 30(3):371-373. PMID: 28484069

Seibert RG, Hanchate AD, Berz JP, Schroy PC. National Disparities in Colorectal Cancer Screening Among Obese Adults. Am J Prev Med. 2017 Aug; 53(2):e41-e49.View Related Profiles.

Hanchate, Amresh
Berz, Jonathan
Schroy, Paul
Seibert, Ryan

PMID: 28236517; DOI: 10.1016/j.amepre.2017.01.006;

Rohan EA, Slotman B, DeGroff A, Morrissey KG, Murillo J, Schroy P. Refining the Patient Navigation Role in a Colorectal Cancer Screening Program: Results From an Intervention Study. J Natl Compr Canc Netw. 2016 Nov; 14(11):1371-1378. PMID: 27799508; PMCID: PMC5419036

Showing 10 of 182 results. Show More

Lowery JT, Ahnen DJ, Schroy PC, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016 Sep 01; 122(17):2633-45. PMID: 27258162; PMCID: PMC5575812; DOI: 10.1002/cncr.30080;

Ahnen DJ, Schroy PC, Weber TK. Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy". Clin Gastroenterol Hepatol. 2016 11; 14(11):1668-1669. PMID: 27266981; DOI: 10.1016/j.cgh.2016.05.037;

Schroy PC, Duhovic E, Chen CA, Heeren TC, Lopez W, Apodaca DL, Wong JB. Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial. Med Decis Making. 2016 May; 36(4):526-35.View Related Profiles.

Chen, Clara
Schroy, Paul
Heeren, Timothy

PMID: 26785715; PMCID: PMC4818180; DOI: 10.1177/0272989X15625622;

Calderwood AH, Schroy PC, Kluge MA, Cabral HJ, Burgess JF. Predictors of Adherence to Post-Polypectomy Surveillance Colonoscopy. J Health Care Poor Underserved. 2016; 27(1):261-279.View Related Profiles.

Cabral, Howard
Burgess, James
Schroy, Paul

PMID: 27763469

Berger BM, Schroy PC, Dinh TA. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness. Clin Colorectal Cancer. 2016 Sep; 15(3):e65-74. PMID: 26792032; DOI: 10.1016/j.clcc.2015.12.003;

Calderwood AH, Thompson KD, Schroy PC, Lieberman DA, Jacobson BC. Response. Gastrointest Endosc. 2015 Sep; 82(3):583-4.View Related Profiles.

Calderwood, Audrey
Jacobson, Brian
Schroy, Paul

PMID: 26279354; DOI: 10.1016/j.gie.2015.04.042;

Schroy PC, Wong JB, O'Brien MJ, Chen CA, Griffith JL. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy. Am J Gastroenterol. 2015 Jul; 110(7):1062-71.View Related Profiles.

Chen, Clara
O'Brien, Michael
Schroy, Paul

PMID: 26010311; PMCID: PMC4705553; DOI: 10.1038/ajg.2015.146;

Calderwood AH, Thompson KD, Schroy PC, Lieberman DA, Jacobson BC. Good is better than excellent: bowel preparation quality and adenoma detection rates. Gastrointest Endosc. 2015 Mar; 81(3):691-699.e1.View Related Profiles.

Calderwood, Audrey
Jacobson, Brian
Schroy, Paul

PMID: 25708756; PMCID: PMC4339796; DOI: 10.1016/j.gie.2014.10.032;

Calderwood AH, Logan JR, Zurfluh M, Lieberman DA, Jacobson BC, Heeren TC, Schroy PC. Validity of a Web-based educational program to disseminate a standardized bowel preparation rating scale. J Clin Gastroenterol. 2014 Nov-Dec; 48(10):856-61.View Related Profiles.

Calderwood, Audrey
Jacobson, Brian
Schroy, Paul
Heeren, Timothy

PMID: 24463841; PMCID: PMC4108578; DOI: 10.1097/MCG.0000000000000028;

Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy PC. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Am J Gastroenterol. 2014 Dec; 109(12):1922-32.View Related Profiles.

Chen, Clara
Farraye, Francis
O'Brien, Michael
Schroy, Paul
Gould, Ryan
Qazi, Taha

PMID: 25350766; DOI: 10.1038/ajg.2014.325;

Kwah J, Schroy PC, Jacobson BC, Calderwood AH. Erratum to: Whites and Blacks Have Similar Risk of Metachronous Advanced Colorectal Neoplasia. Dig Dis Sci. 2014 Oct; 59(10):2604.View Related Profiles.

Jacobson, Brian
Schroy, Paul

PMID: 24908136; DOI: 10.1007/s10620-014-3236-x;

Kwah J, Schroy PC, Jacobson BC, Calderwood AH. Whites and blacks have similar risk of metachronous advanced colorectal neoplasia. Dig Dis Sci. 2014 Sep; 59(9):2264-71.View Related Profiles.

Calderwood, Audrey
Jacobson, Brian
Schroy, Paul

PMID: 24700155; DOI: 10.1007/s10620-014-3132-4;

Calderwood AH, Schroy PC, Lieberman DA, Logan JR, Zurfluh M, Jacobson BC. Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanliness. Gastrointest Endosc. 2014 Aug; 80(2):269-76.View Related Profiles.

Calderwood, Audrey
Jacobson, Brian
Schroy, Paul

PMID: 24629422; PMCID: PMC4104141; DOI: 10.1016/j.gie.2014.01.031;

Schroy PC, Caron SE, Sherman BJ, Heeren TC, Battaglia TA. Risk assessment and clinical decision making for colorectal cancer screening. Health Expect. 2015 Oct; 18(5):1327-38.View Related Profiles.

Sherman, Bonnie
Schroy, Paul
Heeren, Timothy
Battaglia, Tracy

PMID: 23905546; PMCID: PMC4213312; DOI: 10.1111/hex.12110;

Schroy PC, Coe A, Chen CA, O'Brien MJ, Heeren TC. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med. 2013 Jul 2; 159(1):13-20.View Related Profiles.

Chen, Clara
O'Brien, Michael
Schroy, Paul
Heeren, Timothy

PMID: 23817700; PMCID: PMC4218749; DOI: 10.7326/0003-4819-159-1-201307020-00004;

Schroy PC, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvaganam SR, Coe AM, Chen CA, Chaisson CE, Pignone MP, Prout MN, Davidson PK, Heeren TC. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med. 2012 Dec; 43(6):573-83.View Related Profiles.

Chaisson, Christine
Chen, Clara
Prout, Marianne
Schroy, Paul
Heeren, Timothy

PMID: 23159252; PMCID: PMC3966107; DOI: 10.1016/j.amepre.2012.08.018;

Schroy PC, Coe AM, Mylvaganam SR, Ahn LB, Lydotes MA, Robinson PA, Davis JT, Chen CA, Ashba J, Atkinson ML, Colditz GA, Heeren TC. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila). 2012 Aug; 5(8):1044-52.View Related Profiles.

Chen, Clara
Schroy, Paul
Heeren, Timothy

PMID: 22689913; PMCID: PMC3632311; DOI: 10.1158/1940-6207.CAPR-12-0014;

Schroy P, Coe A, Chen C, Heeren T. Gastroenterology. The Prevalence of Advanced Colorectal Neoplasia (ACN) is Lower among Average-Risk Blacks than Whites Undergoing Screening Colonoscopy in a Safety Net Health Care System. 2012.

Schroy PC, Mylvaganam S, Davidson P. Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making. Health Expect. 2014 Feb; 17(1):27-35. PMID: 21902773; PMCID: PMC5060695; DOI: 10.1111/j.1369-7625.2011.00730.x;

Calderwood AH, Schroy PC. Colorectal cancer: Increasing colorectal cancer screening--miles to go. Nat Rev Gastroenterol Hepatol. 2011 Aug; 8(8):421-2.View Related Profiles.

Calderwood, Audrey
Schroy, Paul

PMID: 21750514; DOI: 10.1038/nrgastro.2011.123;

Levitzky BE, Brown CC, Heeren TC, Schroy PC. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011 Jun; 106(6):1099-106.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 21326221; DOI: 10.1038/ajg.2011.20;

Calderwood AH, Wasan SK, Heeren TC, Schroy PC. Patient and Provider Preferences for Colorectal Cancer Screening: How Does CT Colonography Compare to Other Modalities? Int J Canc Prev. 2011; 4(4):307-338.View Related Profiles.

Calderwood, Audrey
Schroy, Paul
Wasan, Sharmeel
Heeren, Timothy

PMID: 25237287; PMCID: PMC4165440

Mitchell SE, Heyden R, Heyden N, Schroy P, Andrew S, Sadikova K, Wiecha J. J Med Internet Res. A Pilot Study of Motivational Interviewing Training in a Virtual World. 2011; 13:e77.
Schroy P, Emmons K, Peters E, Pignone M, Glick J, Robinson P, Lydotes M, Mylvaganam S, Coe A, Evans S, Prout M, Davidson P, Heeren T. Gastroenterology. Shared Decision-Making (SDM) for Colorectal Cancer (CRC) Screening Increases Adherence. 2011; 140(Suppl 1):S-404.

Boehmer U, Harris J, Bowen DJ, Schroy PC. Surveillance after colorectal cancer diagnosis in a safety net hospital. J Health Care Poor Underserved. 2010 Nov; 21(4):1138-51.View Related Profiles.

Bowen, Deborah
Schroy, Paul
Boehmer, Ulrike

PMID: 21099067; DOI: 10.1353/hpu.2010.0918;

Fletcher RH, Nadel MR, Allen JI, Dominitz JA, Faigel DO, Johnson DA, Lane DS, Lieberman D, Pope JB, Potter MB, Robin DP, Schroy PC, Smith RA. The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med. 2010 Nov; 25(11):1230-4. PMID: 20703953; PMCID: PMC2947628; DOI: 10.1007/s11606-010-1446-2;

Schroy PC, Emmons K, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvanaman S, Evans S, Chaisson C, Pignone M, Prout M, Davidson P, Heeren TC. The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making. 2011 Jan-Feb; 31(1):93-107.View Related Profiles.

Chaisson, Christine
Prout, Marianne
Schroy, Paul
Davidson, Peter
Heeren, Timothy

PMID: 20484090; PMCID: PMC4165390; DOI: 10.1177/0272989X10369007;

Schroy PC. Cecil Essentials of Medicine (Andreoli TE, ed.). Neoplasms of the gastrointestinal tract. Saunders. Philadelphia. 2010; 439-444.
Wasan S, Schroy PC. Gastroenterology. New colorectal cancer screening (CRC) guidelines unlikely to change primary care provider preferences. 2010; 138(Suppl 1):A77.

Schroy PC, Glick JT, Robinson P, Lydotes MA, Heeren TC, Prout M, Davidson P, Wong JB. A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial. Clin Trials. 2009 Dec; 6(6):597-609.View Related Profiles.

Prout, Marianne
Schroy, Paul
Davidson, Peter
Heeren, Timothy

PMID: 19933718; DOI: 10.1177/1740774509346703;

Wasan SK, Schroy PC. Water-assisted unsedated colonoscopy: does the end justify the means? Gastrointest Endosc. 2009 Mar; 69(3 Pt 1):551-3.View Related Profiles.

Schroy, Paul
Wasan, Sharmeel

PMID: 19231498; DOI: 10.1016/j.gie.2008.10.045;

Schroy PC, Heeren T. Gastroenterology. Prevalence and distribution of advanced colorectal neoplasia among whites and blacks undergoing screening colonoscopy. 2009; 136(Suppl 1):A-624.
Jacobson BC, Schroy PC. Educational Review Manual in Gastroenterology (Wolfe MM, Lowe RC, eds.). Gastrointestinal malignancies. Castle Connolly Graduate Medical Publishing. New York. 2009.

Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol. 2008 Nov; 103(11):2862-70. PMID: 18759824; DOI: 10.1111/j.1572-0241.2008.02088.x;

Schroy PC, Glick JT, Wilson S, Robinson PA, Heeren TC. An effective educational strategy for improving knowledge, risk perception, and risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2008 Jul; 42(6):708-14.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 18574393; DOI: 10.1097/MCG.0b013e3180500318;

Holt CL, Schroy PC. A new paradigm for increasing use of open-access screening colonoscopy. Clin Gastroenterol Hepatol. 2008 Apr; 6(4):377-8. PMID: 18387496; DOI: 10.1016/j.cgh.2008.02.015;

Schroy PC, Glick JT, Robinson PA, Lydotes MA, Evans SR, Emmons KM. Has the surge in media attention increased public awareness about colorectal cancer and screening? J Community Health. 2008 Feb; 33(1):1-9. PMID: 18080203

Schroy P, Emmons K, Peters E, Glick J, Robinson P, Lydotes M, Mylvaganam S, Evans S, Prout M, Davidson P, Pignone, M. 30th Annual Meeting of the Society for Medical Decision Making. A computer-based decision aid for colorectal cancer (CRC) screening increases patient knowledge, satisfaction with decision-making and intention to be screened. 2008; 30:71.
Schroy PC, Ahn L, Glick JT, Robinson PA, Lydotes M, Mylvaganam S, Ashba J, Atkinson M, Colditz G. Gastroenterology. Your Disease Risk (YDR) and risk stratification for advanced colorectal neoplasia (ACN). 2008; 134(Suppl):185.
Itzkowitz SH, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, Paszat L, Berger B. Gastroenterology. Non-invasive colorectal cancer screening using a simplified stool DNA test. 2008; 134(Suppl):483.

Noe M, Schroy P, Demierre MF, Babayan R, Geller AC. Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices. Cancer Causes Control. 2008 Feb; 19(1):1-12.View Related Profiles.

Schroy, Paul
Babayan, Richard

PMID: 17906935

Schroy PC, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care. 2007 Jul; 13(7):393-400.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 17620034

Lieberman D, Nadel M, Smith RA, Atkin W, Duggirala SB, Fletcher R, Glick SN, Johnson CD, Levin TR, Pope JB, Potter MB, Ransohoff D, Rex D, Schoen R, Schroy P, Winawer S. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007 May; 65(6):757-66. PMID: 17466195

Schroy Iii PC, Glick JT, Robinson PA, Heeren T. Screening preferences of patients at familial risk of colorectal cancer. Dig Dis Sci. 2007 Oct; 52(10):2788-95.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 17404844

Pratap A, Schroy PC. Physical activity and colorectal cancer survival: the more METS the better. Gastroenterology. 2007 Jan; 132(1):456-8. PMID: 17241898

Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde CN, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees. J Cancer Educ. 2007; 22(4):219-26. PMID: 18067433

Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: data from a national survey. J Cancer Educ. 2007; 22(4):208-18. PMID: 18067432

Blanton W, Schroy P, Farraye FA. Am J Gastroenterol. An unusual case of headache in a patient with ulcerative colitis. 2007; 102:S298.
Schroy PC, Glick J, Robinson P, Lydotes M, Evans S, Emmons K. Gastroenterology. Has the surge in media attention increased public knowledge about colorectal cancer (CRC) and screening?. 2007; 132:A-622.
Pratap A, Heeren T, Schroy PC. Gastroenterology. Factors associated with colonoscope withdrawal time during screening colonoscopy. 2007; 132:A-643.
Schroy PC. Cecil Essentials of Medicine (Andreoli TE, ed.). Neoplasms of the gastrointestinal tract. Saunders. Philadelphia. 2007; 415-420.

Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):111-7. PMID: 17161655

Mishkin DS, Schroy PC. Double-balloon endoscopy: Extending the arm of the gastroenterologist. Gastroenterology. 2006 Sep; 131(3):969-71. PMID: 16952572

Farraye FA, Schroy PC. Chromoendoscopy: a new vision for colonoscopic surveillance in IBD. Gastroenterology. 2006 Jul; 131(1):323-5; discussion 325-6.View Related Profiles.

Farraye, Francis
Schroy, Paul

PMID: 16831617

Jacobson BC, Schroy PC. The skinny on obesity and reflux. Gastroenterology. 2006 May; 130(6):1925-6.View Related Profiles.

Jacobson, Brian
Schroy, Paul

PMID: 16697760

Syngal S, Stoffel E, Chung D, Willett C, Schoetz D, Schroy P, Jagadeesh D, Morel K, Ross M. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer. 2006 Jan 15; 106(2):277-83. PMID: 16342248

Berger BM, Schroy PC, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin Colorectal Cancer. 2006 Jan; 5(5):338-43. PMID: 16512992

Ahn LB, Schroy PC. Statins and colorectal cancer risk: a new panacea? Gastroenterology. 2006 Jan; 130(1):278-80. PMID: 16401495

Itzkowitz S, Jandorf L, Brand R, Rabeneck L, Schroy P, Sontag S, Johnson D, Skoletsky J, Shuber S. Gastroenterology. Improved Performance of a Non-Invasive Stool DNA (sDNA) Test to Screen for Colorectal Cancer (CRC). 2006; 130(Suppl 2):A-272.
Glick J, Wilson S, Robinson P, Heeren T, Schroy P. Gastrointestinal Endoscopy. An Effective Educational Strategy for Improving Knowledge, Risk Perception and Risk Communication Among Adenoma Patients. 2006; 63:AB200.
Levitsky B, Brown C, Heeren T, Schroy PC. Gastroenterology. A Prediction Model Based on Age, Gender and Distal Findings Accurately Identifies Black and Hispanic Patients at Low-Risk for Advanced Proximal Colorectal Neoplasia (APN) But Underestimates Absolute Risk. 2006; 130(Suppl 2):A-47.
Schroy PC. Therapy of Digestive Disorders (Wolfe MM, ed.). Neoplastic diseases of the small and large bowel. Saunders Company. Philadelphia. 2006; 887-915.

Oviedo JA, Schroy PC. Does celecoxib use increase the risk of cardiovascular events? Gastroenterology. 2005 Oct; 129(4):1348-50.View Related Profiles.

Oviedo, Jaime
Schroy, Paul

PMID: 16230088

Mishkin DS, Schroy PC. Fecal occult blood testing: Forget the finger! Gastroenterology. 2005 Jul; 129(1):384-6. PMID: 16705773

Lowe R, Schroy PC. Early HVPG measurement and tips for acute variceal hemorrhage: is sooner really better? Gastroenterology. 2005 Apr; 128(4):1136-9; discussion 1139. PMID: 15825100

Schroy PC, Lal SK, Wilson S, Heeren T, Farraye FA. Deficiencies in knowledge and familial risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2005 Apr; 39(4):298-302.View Related Profiles.

Farraye, Francis
Schroy, Paul
Heeren, Timothy

PMID: 15758623

Schroy PC, Glick JT, Geller AC, Jackson A, Heeren T, Prout M. A novel educational strategy to enhance internal medicine residents' familial colorectal cancer knowledge and risk assessment skills. Am J Gastroenterol. 2005 Mar; 100(3):677-84.View Related Profiles.

Prout, Marianne
Schroy, Paul
Heeren, Timothy

PMID: 15743368

Nunes D, Schroy PC. Another step forward: treating HCV infection in HIV coinfected patients. Gastroenterology. 2005 Feb; 128(2):513-5.View Related Profiles.

Nunes, David
Schroy, Paul

PMID: 15685568

Schroy PC, Heeren TC. Patient perceptions of stool-based DNA testing for colorectal cancer screening. Am J Prev Med. 2005 Feb; 28(2):208-14.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 15710277

Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde C, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Am J Gastroenterol. Follow-up of positive colorectal cancer screening tests: data from the second National Colorectal Cancer Roundtable (NCCRT) trainee survey. 2005; 100:S386.
Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde C, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Am J Gastroenterol. Recognition of patients at increased risk for colorectal cancer: data from the second National Colorectal Cancer Roundtable (NCCRT) trainee survey. 2005; 100:S385.

Ferrucci JT, Schroy PC. Virtual colonoscopy: good results and not so good results -- why the difference? Gastroenterology. 2004 Nov; 127(5):1633-5; discussion 1635-6. PMID: 15521030

Bliss CM, Schroy PC. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol. 2004 Sep; 20(5):468-73.View Related Profiles.

Bliss, Charles
Schroy, Paul

PMID: 15689681

Farraye F, Schroy PC. Tailoring use of screening colonoscopy: are we up to the challenge? Gastroenterology. 2004 Aug; 127(2):673-5.View Related Profiles.

Farraye, Francis
Schroy, Paul

PMID: 15300599

Chang M, Schroy PC. Endoscopic colorectal cancer screening--can supply meet demand? Gastroenterology. 2004 May; 126(5):1482-5. PMID: 15131811

Lal SK, Barrison A, Heeren T, Schroy PC. A national survey of flexible sigmoidoscopy training in primary care graduate and postgraduate education programs. Am J Gastroenterol. 2004 May; 99(5):830-6.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 15128345

Bliss CM, Schroy III PC. Primary Intestinal Lymphangiectasia. Curr Treat Options Gastroenterol. 2004 Feb; 7(1):3-6.View Related Profiles.

Bliss, Charles
Schroy, Paul

PMID: 14723832

Bliss CM, Schroy PC. Current Treatment Options in Gastroenterology. Primary intestinal lymphangiectasia. 2004; 7:3-6.
Bliss CM, Schroy PC. Curr Opin Gastroenterol. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. 2004; 20:468-473.
Jacobson BC, Schroy PC. Educational Review Manual in Gastroenterology (Wolfe MM, Lowe RC, eds.). Gastrointestinal malignancies. Castle Connolly Graduate Medical Publishing, Ltd. New York. 2004.
Schroy PC. Cecil Essentials of Medicine (Andreoli TE, ed.). Neoplasms of the gastrointestinal tract. Saunders. Philadelphia. 2004; 373-378.
Goel N, Pardi D, Vierkant R, Petersen W, Kolars J, Flinchbaugh R, Wilson T, Sharpe K, Bond J, Smith R, Levin B, Pope J, Schroy P, Limburg P. Proceedings of the 2004 Gastrointestinal Cancer Symposium sponsored by the American Society of Clinical Oncology. Perceived adequacy of colorectal cancer screening education among primary care residents: results of the National Colorectal Cancer Roundtable survey. 2004.
Petersen W, Petersen W, Goel N, Pardi D, Kolars J, Flinchbaugh R, Wilson T, Sharpe K, Bond J, Smith R, Levin B, Pope J, Schroy P, Limburg P. 28th Annual Meeting of the American Society of Preventive Oncology. Colorectal cancer (CRC) screening education methods employed in primary care training programs: data from the National Colorectal Cancer Roundtable Survey. 2004.
Schroy P, Glick J, Geller A, Jackson A, Prout M. Gastroenterology. A novel educational strategy to enhance internal medicine (IM) residents’ familial colorectal cancer risk assessment and management skills. 2004; 126:S1329.
Lal S, Zamor P, Glick J, Heeren T, Schroy P. Gastroenterology. Colonoscopy and stool-based DNA testing preferred for routine colorectal cancer screening (CRCS). 2004; 126:M1498.
Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond J, Smith R, Levin B, Pope JB, Schroy PC, Limburg PL. Gastroenterology. Barriers/motivators of colorectal cancer (CRC) screening in primary care; results of the National Colorectal Cancer Roundtable (NCCRT) survey. 2004; 126:M1481.
Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond J, Smith R, Levin B, Pope JB, Schroy PC, Limburg PL. Gastroenterology. Self-assessed priority level of common preventive health services relative to colorectal cancer (CRC) screening among primary care residents. 2004; 126:M1480.

Barrison AF, Smith C, Oviedo J, Heeren T, Schroy PC. Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am J Gastroenterol. 2003 Jun; 98(6):1410-6.View Related Profiles.

Oviedo, Jaime
Schroy, Paul
Heeren, Timothy

PMID: 12818289

Syngal S, Chung D, MD, Willett C, Schoetz D, Schroy P, Stoffel E, Jagadeesh D, Morel K, Ross M. Gastroenterology. The loss of stool DNA mutation abnormalities in colorectal neoplasia after treatment. 2003; 124:A-5.
Schroy P, Lal S, Heeren T, Wilson S, Geller A, Farraye FA. Gastroenterology. Familial colorectal cancer (CRC) risk communication among colorectal adenoma (CRA) patients. 2003; 124:A-547.
Schroy P, Heeren T. Gastroenterology. A comparative study of patient perceptions and screening preferences for stoolbased DNA testing (SBDNA), fecal occult blood testing (FOBT) or colonoscopy (CS). 2003; 124:A-77.

Levin B, Smith RA, Feldman GE, Colditz GA, Fletcher RH, Nadel M, Rothenberger DA, Schroy PS, Vernon SW, Wender R. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer. 2002 Oct 15; 95(8):1618-28. PMID: 12365008

Schroy PC, Heeren T, Bliss CM, Bliss CM, Pincus J, Wilson S, Prout M. On-site screening sigmoidoscopy promotes long-term utilization but fails as a venue for training primary care endoscopists. Gastroenterology. 2002 May; 122(5):1226-34.View Related Profiles.

Bliss, Charles
Prout, Marianne
Schroy, Paul
Heeren, Timothy

PMID: 11984508

Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002 Apr; 97(4):1031-6. PMID: 12008667

Schroy PC. Medscape Gastroenterology eJournal. Barriers to colorectal cancer screening. Part 1: Patient noncompliance. 2002; 4(2).
Schroy PC. Medscape Gastroenterology eJournal. Barriers to colorectal cancer screening. Part 2: Provider underutilization and restricted access. 2002; 4(3).
Syngal S, Chung D, Willett C, Schoetz D, Schroy P, Stoffell E, Jagadeesh D, Morel K, Ross M. Am J Gastroenterol. Stool DNA analysis for the detection and follow-up of colorectal cancer (CRC) and advanced adenomas (AA): Sensitivity in a prospective series. 2002; 97:S109.
Lal SK, Heeren T, Schroy PC. Gastroenterology. A national survey of flexible sigmoidoscopy (FS) training in primary care education programs. 2002; 122:A-40.

Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001 Dec; 16(12):822-30. PMID: 11903761; PMCID: PMC1495302

Schroy PC, Geller AC, Crosier Wood M, Page M, Sutherland L, Holm LJ, Heeren T. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists. Prev Med. 2001 Nov; 33(5):381-91.View Related Profiles.

Schroy, Paul
Heeren, Timothy

PMID: 11676578

Schroy PC. Primary Care and General Medicine (Noble J, ed.). Gastrointestinal and Liver Tumors. Mosby. St Louis. 2001; 943-962.
Barrison AF, Smith C, Schroy PC. Gastroenterology. Colorectal cancer (CRC) screening and familial risk: a survey of Internal Medicine residents’ knowledge and practice patterns. 2001; 120:A603.

Pho K, Geller A, Schroy PC. Lack of communication about familial colorectal cancer risk associated with colorectal adenomas (United States). Cancer Causes Control. 2000 Jul; 11(6):543-6. PMID: 10880036

Schroy PC. Therapy of Digestive Disorders (Wolfe M, ed.). Polyps, adenocarcinomas and other intestinal tumors. WB Saunders Company. Philadelphia. 2000; 645-673.

Geller AC, Prout MN, Sun T, Krane R, Schroy PC, Demierre MF, Benjes LS, Abd-El-Baki J, Mozden P, Koh HK, Stanfield L. Cancer skills laboratories for medical students: a promising approach for cancer education. J Cancer Educ. 2000; 15(4):196-9.View Related Profiles.

Stanfield, Lorraine
Prout, Marianne
Schroy, Paul

PMID: 11199234

Pho K, Geller A, Schroy PC. Gastroenterology. Lack of communication about familial colorectal cancer risk associated with colorectal adenomas. 2000; 118:A1406.
Ling BS, Schroy PC, Moskowitz MA. 2000 Annual Meeting of the Society of General Internal Medicine. Patient desire for decision-making in colorectal cancer screening. 2000.
Yucaitis JA, Stein L, Pressman J, Chasen R, Schroy PC, Ahnen D. Gastroenterology. Why do patients undergo colonoscopy and their incidence rates of colorectal neoplasia. 2000; 118:A270.
Barrison A, Ling B, Geller AC, Schroy PC. Gastroenterology. Family history and colorectal cancer (CRC) screening: a survey of physician knowledge and practice patterns. 2000; 118:A40.

Fenlon HM, Nunes DP, Schroy PC, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999 Nov 11; 341(20):1496-503.View Related Profiles.

Nunes, David
Schroy, Paul

PMID: 10559450

Schroy PC, Heeren T, Bliss CM, Pincus J, Wilson S, Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 1999 Aug; 117(2):304-11.View Related Profiles.

Bliss, Charles
Prout, Marianne
Schroy, Paul
Heeren, Timothy

PMID: 10419910

Ling BS, Moskowittz MA, Schroy PC. Gastroenterology. Colorectal cancer screening preferences by patients. 1999; 116:A499.

Lucas W, Schroy PC. Reversible ischemic colitis in a high endurance athlete. Am J Gastroenterol. 1998 Nov; 93(11):2231-4. PMID: 9820403

Schroy PC, Geller A, Sutherland L, Palombo R, Brooks D, Holm L, Supran S, Page M, Wood MC. Gastroenterology. A primary care survey of beliefs and practices related to colorectal cancer (CRC) screening. 1998; 114:A675.
Schroy PC, Bliss CM, Bliss CM Jr, Pincus J, Wilson S, Heeren T. Gastroenterology. On-site flexible sigmoidoscopy (FS) influences colorectal cancer screening practices by primary care providers (PCP). 1998; 114:A676.
Ling BS, Moskowitz MA, Schroy PC. AHCPR/HRSA Annual Trainee Meeting. Patient preferences in screening for colorectal cancer. 1998.

Schroy PC. Per-procedure endoscopy costs. Gastrointest Endosc. 1997 Jul; 46(1):90-1. PMID: 9260718

Vosburgh E, Schroy PC. UpToDate (Rose BD, ed.). Gastrointestinal lymphoma: management. UpToDate. Wellesley. 1997.
Cohen SB, Schroy PC. UpToDate (Rose BD, ed.). Gastrointestinal lymphoma: clinical presentation and diagnosis. UpToDate. Wellesley. 1997.
Schroy PC, Nikulasson S. UpToDate (Rose BD, ed.). Gastrointestinal lymphoma: classification and pathology. UpToDate. Wellesley. 1997.
Cohen SB, Schroy PC. UpToDate (Rose BD, ed.). Clinical features and diagnosis of gastric cancer. UpToDate. Wellesley. 1997.
Schroy PC, Nikulasson S. UpToDate (Rose BD, ed.). Gastric cancer: pathology, pathogenesis and risk factors. UpToDate. Wellesley. 1997.

Schroy PC, Wilson S, Afdhal N. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system. Am J Gastroenterol. 1996 Jul; 91(7):1331-7. PMID: 8677989

Singh P, Dai B, Yallampalli U, Lu X, Schroy PC. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Endocrinology. 1996 May; 137(5):1764-74. PMID: 8612513

Cohen S, Nikulasson S, Kupchik H, Carney W, Schroy P. Gastroenterology. Immunohistochemical (IHC) detection of mutant p21ras in colorectal adenomas. 1996; 110:A505.
Schroy PC. Primary Care and General Medicine (Noble J, ed.). Gastrointestinal and Liver Tumors. Mosby. St Louis. 1996; 634-650.

Schroy PC, Brown-Shimer S, Kim K, Johnson KA, Murnane MJ, Yang S, O'Brien MJ, Carney WP, Kupchik HZ. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer. 1995 Jul 15; 76(2):201-9.View Related Profiles.

Murnane, Mary
O'Brien, Michael
Schroy, Paul
Yang, Shi

PMID: 8625092

Salomons HA, Kramer P, Nikulasson S, Schroy PC. Endoscopic features of long-standing primary intestinal lymphangiectasia. Gastrointest Endosc. 1995 May; 41(5):516-8. PMID: 7615236

Schroy PC, Wilson S, Afdhal N, Boston City Hospital Colorectal Cancer Screening Group. Gastrointest Endoscopy. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endosheath system. 1995; 41:354.
Schroy PC, Brown-Shimer S, Kim K, Murname MJ, Yang S, Carney WP, O’Brien MJ, Kupchik HK. Tumor Biology. Clinicopathologic correlation of p21ras mutations in colorectal adenomas. 1995.
Schroy PC, Wilson S, Afdhal N, Boston City Hospital Colorectal Cancer Screening Group. Am J Gastroenterology. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endosheath system. 1995; 90:1651.

Schroy PC, Rustgi AK, Ikonomu E, Liu XP, Polito J, Andry C, O'Keane JC. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol. 1994 Oct; 161(1):111-23.View Related Profiles.

Andry, Christopher
Schroy, Paul

PMID: 7929596

Kupchik HZ, Schroy PC, Kim K, Brown-Shimer, Carney WP. Tumor Biology. Analysis of RAS mutations in human colonic adenomas, carcinomas and normal mucosae. 1994; 15:111.
Schroy PC, Kupchik HZ, Brown-Shimer S, Kim K, Murnane M, Yang S, Carney WP, O’Brien MJ. Gastroenterology. Detection of K-ras mutations in colorectal adenomas and carcinomas by ELISA. 1994; 106:A439.
Schroy PC, Hesketh PC. Current Therapy in Gastroenterology and Liver Disease-4 (Bayless TM, ed.). Colorectal Carcinoma: Adjuvant Therapy. Mosby. St. Louis. 1994; 460-465.
Kupchik HZ, Yang S, Schroy PC, O’Keane JC, O’Brien MJ. Tumor Biology. Characterization of human colorectal adenomas during long term in vitro culture. 1993; 14:225-226.
Cohen SB, Rustigi AK, Liu XP, Mitty RD, Schroy PC. Gastroenterology. Upregulation of PKCa and PKCd accompanies enterocytic differentiation of Caco-2 cells. 1993; 104:393A.
Singh P, Schroy PC, Liu XP, Yallampali U. Gastroenterology. Spontaneous differentiation of Caco-2 cells is associated with significant changes in expression and secretion of IGF-II, IGF-BP2 and IGF-BP4. 1993; 104:855A.

Kelly CP, O'Keane JC, Orellana J, Schroy PC, Yang S, LaMont JT, Brady HR. Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am J Physiol. 1992 Dec; 263(6 Pt 1):G864-70.View Related Profiles.

Schroy, Paul
Yang, Shi

PMID: 1362041

O’Keane JC, Yang S, Gottlieb LS, Schroy PC, O’Brien MJ. Gastroenterology. Description of proliferative activity in colorectal adenomas and comparision of methodologies. 1992; 102:A384.
Schroy PC, Gao N, Rustgi A. Gastroenterology. Upregulation of PKCa in post-confluent growth-inhibited HT29 colon cancer cells. 1992; 102:A394.
O’Keane JC, Yang S, Schroy P, Gottlieb LS, O’Brien MJ. Modern Pathology. Relationship of cell proliferation to evolution of malignancy in adenomas revealed by mapping of proliferation zones. 1992; 5:46A.
Schroy PC, Gao N, Rustgi A. Gastroenterology. Upregulation of PKCa in post-confluent growth-inhibited HT29 colon cancer cells. 1992; 102:A394.

McQuillen DP, Schroy PC, Hesketh PJ, Sugar AM. Pneumocystis carinii pneumonia complicating somatostatin therapy of Cushing's syndrome in a patient with metastatic pancreatic islet cell carcinoma and Zollinger-Ellison syndrome. Am J Gastroenterol. 1991 Apr; 86(4):512-4. PMID: 1672788

Schroy P, Rustgi A, Ikonomu E, Polito J, O’Keane JC. Gastroenterology. Growth inhibition and differentiation are independently regulated in HT29 colon cancer cells. 1991; 100:A399.
Orellana J, Brady HR, O’Keane JC, Schroy PC, Shi Y, LaMont JT, Kelly CP. Gastroenterology. Human colonic carcinoma cells express the cell adhesion molecule ICAM-1. 1991; 100:A392.
Yang S, O’Keane JC, Kupchik HZ, Schroy PC, O’Brien MJ. J Cell Biol (Part 2). Proliferative and morphologic characteristics of colorectal adenomas that relate to cell proliferation in long-term in vitro culture. 1991; 115:228a.

Schroy PC, Cohen A, Winawer SJ, Friedman EA. Effects of FUdR on primary-cultured colon carcinomas metastatic to the liver. J Surg Oncol. 1990 Dec; 45(4):217-23. PMID: 2147452

O'Keane JC, Kupchik HZ, Schroy PC, Andry CD, Collins E, O'Brien MJ. A three-dimensional system for long-term culture of human colorectal adenomas. Am J Pathol. 1990 Dec; 137(6):1539-47.View Related Profiles.

Andry, Christopher
O'Brien, Michael
Schroy, Paul

PMID: 2260636; PMCID: PMC1877731

Schroy P, Rifkin J, Coffey RJ, Winawer S, Friedman E. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res. 1990 Jan 15; 50(2):261-5. PMID: 2295065

Schroy PC. Current Therapy in Gastroenterology and Liver Disease – 3 (Bayless TM, ed). Gastric cancer. BC Decker Inc. Philadelphia. 1990; 11-115.
Kupchik, HZ, O’Brien MJ, Schroy PC, O’Keane JC, Andry CD, and Collins, EA. Proceedings of the International Society for Oncodevelopmental Biology and Medicine, 1990. Three-dimensional in vitro primary culture of benign malignant human tissues. 1990.
Schroy P, O’Brien MJ, O’Keane JC, Collins E, Kupchik H. Gastroenterology. Long-term 3-dimensional cultures of human colorectal adenomas (Ads). 1990; 98:A308.

Schroy P, Winawer S, Friedman E. Effect on in vivo tumorigenicity of lengthy exposure of human colon cancer cells to the differentiation agent hexamethylene bisacetamide. Cancer Lett. 1989 Nov 15; 48(1):53-8. PMID: 2819696

O’Brien MJ, Kupchik H, Schroy P, O’Keane C. Proceedings of the 2nd International Conference on Gastrointestinal Cancer. Experimental models for the study of colorectal adenomas. 1989; 30.
Schroy P, Cohen A, Winawer SJ, Friedman EA. Gastroenterology. Differential sensitivity of primary-cultured metastatic colon carcinoma cells and endothelial cells to FudR. 1989; A454.

Schroy PC, Carnright K, Winawer SJ, Friedman EA. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide. Cancer Res. 1988 Oct 1; 48(19):5487-94. PMID: 2458179

Schroy PC, Wiggins T, Winawer SJ, Diaz B, Lightdale CJ. Video endoscopy by nurse practitioners: a model for colorectal cancer screening. Gastrointest Endosc. 1988 Sep-Oct; 34(5):390-4. PMID: 3181698

Schroy PC, Cohen A, Winawer SJ, Friedman EA. New chemotherapeutic drug sensitivity assay for colon carcinomas in monolayer culture. Cancer Res. 1988 Jun 1; 48(11):3236-44. PMID: 2966672

Berner Y, Schroy P, Hermann-Zaidins M, Shike M. JPEN. Enteral feeding through percutaneous endoscopic jejunostomy (PEJ) in patients with previous gastric resection. 1988; 12:20s.
Schroy PC, Carnright K, Winawer SJ, Friedman EA. Gastroenteology. Malignant to benign colon tumor transition induced by hexamethylene bisacetamide. 1988; 94:A413.
Schroy P, Cohen A, Winawer S, Friedman E. Proceedings of AACR. Inherent drug resistance in untreated human colon carcinomas. 1988; 29:1947.

Shike M, Schroy P, Ritchie MA, Lightdale CJ, Morse R. Percutaneous endoscopic jejunostomy in cancer patients with previous gastric resection. Gastrointest Endosc. 1987 Oct; 33(5):372-4. PMID: 3678765

Schroy P, Carnright K, Winawer SJ, Friedman E. Proceedings of AACR. Malignant to benign human colon tumor conversion by hexamethylene bisacetamide (HMBA). 1987; 28:422.
Schroy P, Ritchie M, Barcia-Morse R, Lightdale CJ, Shike M. Proceedings of ASCO. Home enteral nutrition via endoscopically placed percutaneous gastrostomies. 1987; 6:263.
Schroy PC, Winawer SJ. Current Therapy in Gastroenterology and Liver Disease – 2 (Bayless TM, ed.). Bone marrow transplants: Gastrointestinal considerations. BC Decker Inc. Philadelphia. 1986; 188-192.
Schroy P, Carnright K, Winawer SJ, Friedman E. Proceedings of AACR. Induced differentiation of human tumors in primary culture by HMBA. 1986; 27:42.
Schroy P, Carnright K, Winawer SJ, Friedman E. Gastroenterology. Differentiation of human colon carcinomas in primary culture. 1986; 90:1621.
Ritchie M, Barcia-Morse R, Schroy P, Lightdale CJ, Kelsen D, Shike M. Gastroenterology. Home enteral feeding through endoscopic gastronomies in cancer patients. 1986; 90:1605.

Flombaum CD, Schroy P, Watson R, Vanamee P. Treatment of acute obstructive renal failure with high-dose methylprednisolone. Arch Intern Med. 1986 Jan; 146(1):58-61. PMID: 3510599

Goel N, Pardi D, Petersen W, Vierkant R, Pankrantz, Kolars J, Flinchbaugh R, Wison T, Pope JB, Schroy P, Limburgh P. 95th Annual Meeting of the American Association for Cancer Research. Concordance between preferred and actually recommended colorectal screening options among primary residents: results of a national survey.
Jacobson BC, Schroy PC. Educational Review Manual in Gastroenterology. Gastrointestinal malignancies. Castle Connolly Graduate Medical Publishing, Ltd. New York.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 180 publications over 35 distinct years, with a maximum of 16 publications in 2004

Bar chart showing 180 publications over 35 distinct years, with a maximum of 16 publications in 2004

Year	Publications
1986	5
1987	3
1988	6
1989	3
1990	6
1991	4
1992	5
1993	3
1994	4
1995	5
1996	4
1997	6
1998	4
1999	3
2000	7
2001	4
2002	7
2003	4
2004	16
2005	9
2006	11
2007	11
2008	7
2009	4
2010	5
2011	6
2012	3
2013	2
2014	5
2015	4
2016	5
2017	4
2019	1
2022	3
2023	1

2017-2018 Boston Magazine: Top Doctor

2011 Castle Connolly: Top Doctor in US

2011-2019 Castle Connolly : Top Doctor in Region

2008 Castle Connolly: Top Doctor in Massachusetts

2007 Boston University School of Public Health: Excellence in Teaching Award

2006 American Gastroenterological Association: Fellow

2001 Boston University School of Public Health: Excellence in Teaching Award

2000 American College of Physicians: Fellow

1998 Boston University Schroy of Public Health: Excellence in Teaching Award

1998 Boston University School of Public Health : Delta Omega Honor Society

1988 American College of Gastroenterology: Fellow

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Colorectal cancer screening
Shared decision making
Risk Factors
Epidemiology

Dr. Schroy has mentored 18 students, house staff, fellows and junior faculty on various research projects related to his areas of expertise. Many of his mentees have pursued careers in academic medicine at various institutions around the country.

Available to Mentor as: (Review Mentor Role Definitions):

Research / Scholarly Mentor

Contact for Mentoring:

85 E. Concord St
Boston MA 02118
Google Map

617.638.8335

Download vCard

Schroy's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (300) concept(s)

Co-Authors

See all (20) people

Similar People

See all (60) people

Same Department

Search Department